BibTex Citation Data :
@article{NMJN48272, author = {Dwi Rukmi and Muhamat Nofiyanto}, title = {Chemotherapy-Induced Nausea and Vomiting (CINV) Based on Blood Types among Cancer Patients in Yogyakarta, Indonesia}, journal = {Nurse Media Journal of Nursing}, volume = {13}, number = {2}, year = {2023}, keywords = {Blood group; CINV; cancer; Yogyakarta}, abstract = { Background: Studies related to blood type in cancer patients have been conducted extensively, but they are inclined to cancer incidence or survival rate. Meanwhile, there is limited research on Chemotherapy-Induced Nausea and Vomiting (CINV), the most disturbing side effect of chemotherapy, in relation to blood type. Purpose: This study aimed to compare CINV frequency in cancer patients by blood groups in Yogyakarta, Indonesia. Methods: A descriptive comparative study with a cross-sectional approach was conducted purposively on 70 chemotherapy patients in two hospitals in Yogyakarta. Patients with anticipatory CINV and brain cancer (primary or metastases) were excluded. The data were collected between July and November 2020 using a sheet for patient characteristics and a filled-in diary from the first to the seventh day post-chemotherapy to collect CINV data. The descriptive statistics and Kruskal Wallis test were used to analyze the data. Results: Of 70 total samples, most of them were breast cancer (71.4%) and were in stage IV (50%). They received chemotherapy alone as their primary therapy (94.3%) and received moderate to high emetogenic agents (31.4% and 35.7%). Samples mostly had A blood type (34.3%) and had undergone chemotherapy for 3-18 months (min-max). As many as 64.6% of patients experienced CINV with a delayed type and experienced moderate severity (52.9%). The bivariate test showed no difference in CINV frequencies based on blood groups in general ( p =0.068). However, based on the CINV onset, there was a significant difference in CINV frequencies in the A blood group against other blood groups ( p =0.020) on the fourth post-chemotherapy day. Conclusions: Unless the fourth-day post-chemotherapy, the frequency of CINV based on blood groups showed no difference. Since CINV incidence is still high, the provision of both pharmacological and non-pharmacological therapy to treat CINV has to be given to patients after chemotherapy. Blood group factors can be considered for more extensive management, especially in delayed CINV cases. }, issn = {2406-8799}, pages = {176--187} doi = {10.14710/nmjn.v13i2.48272}, url = {https://ejournal.undip.ac.id/index.php/medianers/article/view/48272} }
Refworks Citation Data :
Background: Studies related to blood type in cancer patients have been conducted extensively, but they are inclined to cancer incidence or survival rate. Meanwhile, there is limited research on Chemotherapy-Induced Nausea and Vomiting (CINV), the most disturbing side effect of chemotherapy, in relation to blood type.
Purpose: This study aimed to compare CINV frequency in cancer patients by blood groups in Yogyakarta, Indonesia.
Methods: A descriptive comparative study with a cross-sectional approach was conducted purposively on 70 chemotherapy patients in two hospitals in Yogyakarta. Patients with anticipatory CINV and brain cancer (primary or metastases) were excluded. The data were collected between July and November 2020 using a sheet for patient characteristics and a filled-in diary from the first to the seventh day post-chemotherapy to collect CINV data. The descriptive statistics and Kruskal Wallis test were used to analyze the data.
Results: Of 70 total samples, most of them were breast cancer (71.4%) and were in stage IV (50%). They received chemotherapy alone as their primary therapy (94.3%) and received moderate to high emetogenic agents (31.4% and 35.7%). Samples mostly had A blood type (34.3%) and had undergone chemotherapy for 3-18 months (min-max). As many as 64.6% of patients experienced CINV with a delayed type and experienced moderate severity (52.9%). The bivariate test showed no difference in CINV frequencies based on blood groups in general (p=0.068). However, based on the CINV onset, there was a significant difference in CINV frequencies in the A blood group against other blood groups (p=0.020) on the fourth post-chemotherapy day.
Article Metrics:
Last update:
Last update: 2023-12-03 04:23:20
Authors submitting a manuscript do so on the understanding that if accepted for publication, copyright of the article shall be assigned to Nurse Media Journal of Nursing and Department of Nursing, Faculty of Medicine, Diponegoro University as the publisher of this journal.
Copyright encompasses exclusive rights to reproduce and deliver the article in all forms and media, including reprints, photographs, microfilms and any other similar reproductions, as well as translations. The reproduction of any part of this journal, its storage in databases and its transmission by any forms or media, such as electronic, electrostatic and mechanical copies, photocopies, recordings, magnetic media, etc., will be allowed only with a written permission from Nurse Media Journal of Nursing and Department of Nursing, Faculty of Medicine, Diponegoro University.
Nurse Media Journal of Nursing and Department of Nursing, Faculty of Medicine, Diponegoro University make every effort to ensure that no wrong or misleading data, opinions or statements be published in the journal. In any way, the contents of the articles and advertisements published in Nurse Media Journal of Nursing are sole and exclusive responsibility of their respective authors and advertisers.
The Copyright Transfer Agreement Form can be downloaded by click this link Copyright Transfer Agreement Form. The copyright form should be filled with respect to article and be signed originally and sent to the Editorial Office in the form of original email, or scanned document file (softcopy) to:
Dr. Meira Erawati (Editor-in-Chief)
Department of Nursing, Faculty of Medicine, Diponegoro University
Jl. Prof. Soedarto, Tembalang, Semarang, Central Java, Indonesia 50275
Telp.: +62-24-76480919; Fax.: +62-24-76486849
E-mail: media_ners@live.undip.ac.id